Agree with your comments playez you sum up the situation as it stands.
However that's not news. All who follow POH on here are aware of the situation and recognize the need for management to move into high gear and put a deal on the table.
I believe even POH are awake and that's why we have 3 new execs - Clark, James and Webb:
"As Phosphagenics is building its product pipeline and commercial focus it is also strengthening its board. We welcome our three new Directors who are all commercially savvy and heavy-weights in their respective fields.
What is news is that we completed another successful trial-
"Phosphagenics CEO Dr Esra Ogru, said this pivotal trial provided all necessary dosing and patch information required to proceed to a phase 2/3 program."-
which IMO again derisks and brings us one step closer to commercialization.
POH Price at posting:
10.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)